Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Chung

Showing results (171-180 of 1,616) with videos related to

Pageof 162
Sort By:
The Lancet. Gastroenterology & Hepatology|June 20, 2020
Shortening treatment with direct-acting antivirals in HCV-positive organ transplantationJacinta A Holmes, Raymond T Chung
JHEP Reports : Innovation in Hepatology|December 24, 2024
The future of clinical trials of gut microbiome therapeutics in cirrhosisPatricia P Bloom, Raymond T Chung
Journal of Clinical Epidemiology|October 2, 2023
The use of the E-value for sensitivity analysisWilliam T Chung, Kevin C Chung
Radiologic Clinics of North America|September 6, 2011
Preoperative and postoperative MR evaluation of congenital heart disease in childrenL P Browne, R Krishnamurthy, T Chung
Seminars in Liver Disease|December 23, 2011
The impact of human gene polymorphisms on HCV infection and disease outcomeEsperance A K Schaefer, Raymond T Chung
Cellular and Molecular Gastroenterology and Hepatology|January 27, 2022
A New Model to Assess Hepatitis B Virus Covalently Closed Circular DNA: A Window Into a Previously Hidden Space?Min Xu, Wenyu Lin, Raymond T Chung
Hepatology (Baltimore, Md.)|December 31, 2009
An identification of novel therapy for human hepatocellular carcinoma by using human induced pluripotent stem cellsHisashi Moriguchi, Raymond T Chung, Chifumi Sato
Oncotarget|September 8, 2016
Anti-hepatocellular carcinoma properties of the anti-alcoholism drug disulfiram discovered to enzymatically inhibit the AMPK-related kinase SNARK in vitroKaku Goto, Naoya Kato, Raymond T Chung
Biochemical Pharmacology|May 20, 1998
Stimulation of DNA synthesis in untransformed cells by the antiviral and antitumoral compound tricyclodecan-9-yl-xanthogenate (D609)Z Kiss, K S Crilly, T Chung
Hepatology (Baltimore, Md.)|December 4, 2009
Tumorigenicity of human induced pluripotent stem cells depends on the balance of gene expression between p21 and p53Hisashi Moriguchi, Raymond T Chung, Chifumi Sato
Pageof 162

Showing results (171-180 of 1,616) with videos related to

Sort By:
Pageof 162
The Lancet. Gastroenterology & Hepatology|June 20, 2020
Shortening treatment with direct-acting antivirals in HCV-positive organ transplantationJacinta A Holmes, Raymond T Chung
JHEP Reports : Innovation in Hepatology|December 24, 2024
The future of clinical trials of gut microbiome therapeutics in cirrhosisPatricia P Bloom, Raymond T Chung
Journal of Clinical Epidemiology|October 2, 2023
The use of the E-value for sensitivity analysisWilliam T Chung, Kevin C Chung
Radiologic Clinics of North America|September 6, 2011
Preoperative and postoperative MR evaluation of congenital heart disease in childrenL P Browne, R Krishnamurthy, T Chung
Seminars in Liver Disease|December 23, 2011
The impact of human gene polymorphisms on HCV infection and disease outcomeEsperance A K Schaefer, Raymond T Chung
Cellular and Molecular Gastroenterology and Hepatology|January 27, 2022
A New Model to Assess Hepatitis B Virus Covalently Closed Circular DNA: A Window Into a Previously Hidden Space?Min Xu, Wenyu Lin, Raymond T Chung
Hepatology (Baltimore, Md.)|December 31, 2009
An identification of novel therapy for human hepatocellular carcinoma by using human induced pluripotent stem cellsHisashi Moriguchi, Raymond T Chung, Chifumi Sato
Oncotarget|September 8, 2016
Anti-hepatocellular carcinoma properties of the anti-alcoholism drug disulfiram discovered to enzymatically inhibit the AMPK-related kinase SNARK in vitroKaku Goto, Naoya Kato, Raymond T Chung
Biochemical Pharmacology|May 20, 1998
Stimulation of DNA synthesis in untransformed cells by the antiviral and antitumoral compound tricyclodecan-9-yl-xanthogenate (D609)Z Kiss, K S Crilly, T Chung
Hepatology (Baltimore, Md.)|December 4, 2009
Tumorigenicity of human induced pluripotent stem cells depends on the balance of gene expression between p21 and p53Hisashi Moriguchi, Raymond T Chung, Chifumi Sato
Pageof 162